The Better Sleep for Supporters With Insomnia Study (BeSSI)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04661306 |
|
Recruitment Status :
Active, not recruiting
First Posted : December 10, 2020
Last Update Posted : December 22, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Family Caregivers Cancer Insomnia Sleep Initiation and Maintenance Disorders | Behavioral: SHUTi (Sleep Healthy Using the Internet) | Not Applicable |
Insomnia is a significant public health problem with substantial medical, psychological and financial ramifications. About 50-75% of the 3.5 million Americans who provide unpaid medical, practical, and/or emotional support for a loved one with cancer endorse clinically significant sleep disturbance. Understanding caregivers' psychosocial risk factors and needs, and the extent to which these are unique to the cancer caregiving context, will ensure appropriate and effective interventions for cancer caregivers with insomnia.
Existing psychosocial services for caregivers are primarily delivered in-person. Although such interventions are effective, they suffer from low enrollment, high dropout, and limited reach to caregivers who already have inadequate healthcare access, like caregivers from lower SES or those in rural areas. Digital health interventions can lower barriers to entry to supportive care for caregivers as they are conveniently accessible anywhere and anytime from an Internet-enabled device. Sleep Healthy Using the Internet (SHUTi) is a NCI-designated research-tested intervention that delivers cognitive-behavioral therapy for insomnia (CBT-I) and holds significant potential to accessibly treat insomnia for cancer caregivers. Most digital health interventions tested among caregivers, however, have been developed de novo for specific caregiving contexts. The implicit assumption underlying highly tailored interventions for caregivers is that caregivers have different deficits, risk factors, and needs from non-caregivers. This assumption has not often been tested, and therefore the extent to which caregivers want and need tailoring for digital health interventions is not known. This study is therefore designed to provide the data necessary to ensure the highest quality, impact, and efficiency from existing evidence-based digital health interventions to meet pressing psychosocial needs among cancer caregivers. Specifically, this study will directly inform next research steps for tailoring and testing SHUTi for optimal impact and reach among caregivers.
The SHUTi Program: SHUTi is a self-guided (i.e., automated), interactive, and tailored web-based program modeled on the primary tenants of face-to-face CBT-I (sleep restriction, stimulus control, cognitive restructuring, sleep hygiene, relapse prevention). Intervention content is metered out over time through 6 "Cores." Users obtain access to a new Core based on a time and event-based schedule (e.g., 7 days after completion of previous Core). This schedule is consistent with the recommendation from a task force commissioned by the Academy of Sleep Medicine, which deemed that an average of 6 - 8 sessions constitutes "adequate treatment exposure". The SHUTi program relies on user-entered online Sleep Diaries to track progress and to tailor treatment recommendations (i.e., assign a "sleep restriction" window). Each Core acts as an online analog for the weekly sessions typically used when delivering CBT-I in a face-to-face format, following the same general structure: 1) Core objectives (what will be learned and why this information is important), 2) review of previous week's homework and sleep diary data, 3) new intervention material, 4) assignment of homework (treatment strategies for the coming week), and 5) a summary of the Core's main points. Intervention content is enhanced through a variety of interactive features, including personalized goal-setting, graphical feedback based on inputted symptoms, animations / illustrations to enhance comprehension, quizzes to test user knowledge, patient vignettes, and video-based expert explanation. Automated emails are also sent to encourage program adherence. There is no content that is specifically about cancer or caregiving.
Caregivers participating in this study will complete a baseline assessment (questionnaires and 2 weeks of daily sleep diaries), and then will receive complementary and voluntary access to SHUTi. Participants who choose to complete 1 or more SHUTi Cores will complete a follow-up assessment of questionnaires and 2 weeks of sleep diaries; participants who choose not to complete any SHUTi cores will be asked to provide brief feedback regarding their reasons/barriers.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 14 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Optimizing Efficiency and Impact of Internet-delivered Insomnia Treatment for Cancer Caregivers |
| Actual Study Start Date : | September 30, 2020 |
| Estimated Primary Completion Date : | March 31, 2022 |
| Estimated Study Completion Date : | March 31, 2022 |
| Arm | Intervention/treatment |
|---|---|
| Experimental: SHUTi |
Behavioral: SHUTi (Sleep Healthy Using the Internet)
Cognitive Behavioral Therapy for insomnia delivered online and metered out over 6 weeks in a fully automated, interactive, tailored web-based program
Other Name: CBTi |
- SHUTi Usage [ Time Frame: 9 weeks ]Number of SHUTi Cores completed by participants
- Insomnia severity [ Time Frame: Baseline, 9 weeks ]Insomnia severity index; 7 items; summed scores range from 0 to 28 (higher scores indicate more severe insomnia symptoms)
- Sleep onset latency (SOL) [ Time Frame: Baseline, 9 weeks ]Data collected from sleep diary: Time fell asleep - Time attempting to fall asleep
- Wake after sleep onset (WASO) [ Time Frame: Baseline, 9 weeks ]Data collected from sleep diary: Total time awake between time feel asleep and final morning waking
- Perceived sleep quality [ Time Frame: Baseline, 9 weeks ]Data collected from sleep diary: Nightly rating of perceived sleep quality from very poor to very good
- Sleep-related cognitions [ Time Frame: Baseline, 9 weeks ]Dysfunctional Beliefs and Attitudes about Sleep; 16 items; averaged scores range from 0 to 10 (higher scores indicate more dysfunctional attitudes and beliefs about sleep)
- Sleep self-efficacy [ Time Frame: Baseline, 9 weeks ]Sleep Self-Efficacy Scale; 13-items; averaged scores range from 0 to 10 (higher scores indicate greater self-efficacy)
- Internal and chance sleep locus of control [ Time Frame: Baseline, 9 weeks ]Sleep Locus of Control Scale; 4-item subscales for internal and chance locus of control, respectively; averaged scores per scale range from 1 to 6 (higher scores indicate higher belief in the locus of control measured)
- Caregiving burden [ Time Frame: Baseline, 9 weeks ]Pearlin Stress Scale - Overload subscale; 4 items; averaged scores range from 1 to 4 (higher scores indicate greater perceived burden)
- Caregiving competence [ Time Frame: Baseline, 9 weeks ]Pearlin Stress Scale - Caregiving Competence subscale; 4 items; averaged scores range from 1 to 4 (higher scores indicate greater perceived competence)
- Physical Function [ Time Frame: Baseline, 9 weeks ]PROMIS SF v2.0 - Physical Function 8b; 8 items; scored on a normalized T-score distribution (higher scores indicate higher physical function)
- Anxiety [ Time Frame: Baseline, 9 weeks ]PROMIS SF v2.0 - Anxiety 8a; 8 items; scored on a normalized T-score distribution (higher scores indicate higher anxiety)
- Depression [ Time Frame: Baseline, 9 weeks ]PROMIS SF v2.0 - Depression 8a; 8 items; scored on a normalized T-score distribution (higher scores indicate higher depression)
- Fatigue [ Time Frame: Baseline, 9 weeks ]PROMIS SF v2.0 - Fatigue 8a; 8 items; scored on a normalized T-score distribution (higher scores indicate higher fatigue)
- Sleep Disturbance [ Time Frame: Baseline, 9 weeks ]PROMIS SF v2.0 - Sleep Disturbance 8a; 8 items; scored on a normalized T-score distribution (higher scores indicate higher sleep disturbance)
- Social functioning [ Time Frame: Baseline, 9 weeks ]PROMIS SF v2.0 - Ability to Participant in Social Roles and Activities 8a; 8 items; scored on a normalized T-score distribution (higher scores indicate higher social function)
- Pain Interference [ Time Frame: Baseline, 9 weeks ]PROMIS SF v2.0 - Pain Interference 8a; 8 items; scored on a normalized T-score distribution (higher scores indicate higher pain interference)
- Pain Intensity [ Time Frame: Baseline, 9 weeks ]PROMIS SF v2.0 - Pain Intensity item; 1 item (higher score indicate higher pain intensity)
- Experiences with Internet intervention [ Time Frame: 9 weeks ]Internet Intervention Utility Questionnaire (UQ) for SHUTi; 18 items; items examined individually
- Perceptions of Internet intervention [ Time Frame: 9 weeks ]Internet Intervention Impact and Effectiveness Questionnaire (IEQ) for SHUTi; 29 items; items examined individually
- Adherence to Internet intervention [ Time Frame: 9 weeks ]Internet Intervention Adherence Questionnaire (AQ) for SHUTi; 20 items; items examined individually
- SHUTi Feasibility as assessed by open-ended feedback [ Time Frame: 9 weeks ]Open-ended survey items regarding barriers to using SHUTi
- SHUTi Acceptability as assessed by open-ended feedback [ Time Frame: 9 weeks ]Open-ended survey items regarding appropriateness of SHUTi to address caregivers' sleep needs
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- self-report providing unpaid care (e.g., practical, medical, and/or emotional support) to an adult family member or "family-like" close individual who is either currently undergoing any anti-cancer treatment (e.g., surgery, chemotherapy, radiation, for either curative or palliative intent) or has completed anti-cancer treatment within the past 2 years.
- Insomnia severity index score of 10 or higher
- age 18 and over
- regular access (at least 2/week) and willingness to use a computer and the Internet and check email
- ability to read and speak English
- resident of the US
Exclusion Criteria:
- irregular sleep schedules that prevent the ability to follow intervention recommendations (i.e., with usual bedtimes outside of 8:00pm to 2:00am or arising time outside of 4:00am to 10:00am)
- current psychological treatment for insomnia
- screen positive for a history of psychotic or bipolar disorder; and current severe depression, high risk of suicide, substance use (alcohol, drug) disorder within the past year
- symptoms suggestive of untreated sleep disorders other than insomnia (e.g., obstructive sleep apnea, restless legs syndrome, periodic limb movement disorder)
- presence of uncontrolled medical condition that is deemed to interfere with the study procedures, or put the study participant at undue risk
- Unstable medication regimen (change to schedule or dosage within past 3 months) for a prescription medication regimen thought to impact sleep.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04661306
| United States, Virginia | |
| University of Virginia | |
| Charlottesville, Virginia, United States, 22903 | |
| Principal Investigator: | Kelly Shaffer, PhD | University of Virginia |
Publications:
| Responsible Party: | Kelly Shaffer, PhD, Assistant Professor, University of Virginia |
| ClinicalTrials.gov Identifier: | NCT04661306 |
| Other Study ID Numbers: |
3809 |
| First Posted: | December 10, 2020 Key Record Dates |
| Last Update Posted: | December 22, 2021 |
| Last Verified: | December 2021 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Family Caregivers Cancer Insomnia |
|
Sleep Initiation and Maintenance Disorders Sleep Disorders, Intrinsic Dyssomnias |
Sleep Wake Disorders Nervous System Diseases Mental Disorders |

